Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study ; volume:24 ; number:1 ; day:17 ; month:5 ; year:2024 ; pages:1-7 ; date:12.2024
BMC cancer ; 24, Heft 1 (17.5.2024), 1-7, 12.2024
- Urheber
-
Miao, Lusheng
Miao, Taosheng
Zhang, Ying
Hao, Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12366-8
- URN
-
urn:nbn:de:101:1-2407290933275.255148771436
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miao, Lusheng
- Miao, Taosheng
- Zhang, Ying
- Hao, Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study
Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study
Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Lipid-lowering drugs and risk of rapid renal function decline: a mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study
Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART